Literature DB >> 8205273

Diabetes mellitus and risk of idiopathic dilated cardiomyopathy. The Washington, DC Dilated Cardiomyopathy Study.

S S Coughlin1, D L Pearle, K L Baughman, A Wasserman, M C Tefft.   

Abstract

An epidemiologic study was carried out to examine the possible role of diabetes mellitus and other factors in the development of idiopathic dilated cardiomyopathy. Possible associations with diabetes and other factors were examined by comparing newly diagnosed case patients (n = 129) ascertained from five Washington, DC area hospitals with neighborhood control subjects (n = 258) identified using a random-digit dialing technique. The case patients and control subjects were matched by sex and 5-year age intervals and were compared in the analysis using conditional logistic regression methods. A statistically significant association was observed between idiopathic dilated cardiomyopathy and history of diabetes (relative odds = 2.2; 95% confidence interval: 1.5 to 3.3). The association with diabetes was not explained by race, income, cigarette usage, or hypertension. A total of 28.7% (37/129) of the case patients had a reported history of diabetes, as compared with 13.6% (35/258) of the control subjects (P < 0.05). A possible interactive effect was also observed between diabetes and history of hypertension (P > 0.05). These findings support the view that diabetics, particularly those with a history of hypertension, may be at increased risk of idiopathic dilated cardiomyopathy.

Entities:  

Mesh:

Year:  1994        PMID: 8205273     DOI: 10.1016/1047-2797(94)90044-2

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  17 in total

Review 1.  Diabetic heart disease.

Authors:  T H Marwick
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

2.  A comparison of ultrastructural changes on endomyocardial biopsy specimens obtained from patients with diabetes mellitus with and without hypertension.

Authors:  M Kawaguchi; M Techigawara; T Ishihata; T Asakura; F Saito; K Maehara; Y Maruyama
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

3.  Chronic respiratory illness as a predictor of survival in idiopathic dilated cardiomyopathy: the Washington, DC, Dilated Cardiomyopathy Study.

Authors:  S A Martin; S S Coughlin; C Metayer; A A René; I W Hammond
Journal:  J Natl Med Assoc       Date:  1996-11       Impact factor: 1.798

4.  What explains black-white differences in survival in idiopathic dilated cardiomyopathy? The Washington, DC, Dilated Cardiomyopathy Study.

Authors:  S S Coughlin; L Myers; R K Michaels
Journal:  J Natl Med Assoc       Date:  1997-04       Impact factor: 1.798

5.  Black-white differences in mortality in idiopathic dilated cardiomyopathy: the Washington, DC, dilated cardiomyopathy study.

Authors:  S S Coughlin; J S Gottdiener; K L Baughman; A Wasserman; E S Marx; M C Tefft; B J Gersh
Journal:  J Natl Med Assoc       Date:  1994-08       Impact factor: 1.798

6.  Marital status as a predictor of survival in idiopathic dilated cardiomyopathy: the Washington, DC dilated cardiomyopathy study.

Authors:  C Metayer; S S Coughlin; E P McCarthy
Journal:  Eur J Epidemiol       Date:  1996-12       Impact factor: 8.082

7.  Addressing Health Disparities in Idiopathic Dilated Cardiomyopathy.

Authors:  Argun D Can; Steven S Coughlin
Journal:  Jacobs J Community Med       Date:  2017-05-09

8.  Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study.

Authors:  Giovanni de Simone; Richard B Devereux; Marcello Chinali; Elisa T Lee; James M Galloway; Ana Barac; Julio A Panza; Barbara V Howard
Journal:  J Hypertens       Date:  2010-02       Impact factor: 4.844

Review 9.  [Heart failure in diabetes].

Authors:  Michael Resl; Martin Hülsmann; Richard Pacher; Martin Clodi
Journal:  Wien Med Wochenschr       Date:  2009

10.  Barriers to cardiac transplantation in idiopathic dilated cardiomyopathy: the Washington, DC, Dilated Cardiomyopathy Study.

Authors:  S S Coughlin; S Halabi; C Metayer
Journal:  J Natl Med Assoc       Date:  1998-06       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.